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Abstract
Background/Aims—Both excitotoxicity and neuroinflammation are associated with oxidative
stress. One transcription factor, Nrf2 and one transcription co-factor PGC-1α, increase the
endogenous antioxidant defense and can thus modulate neuronal cell death. Here we have
investigated the temporal effects (24 and 72 h) of systemic (i.p.) administration of
lipopolysaccharide (LPS) on the cerebral Nrf2 and PGC-1α systems.
Methods and Results—Seven-day old rat pups were injected with LPS (0.3 mg/kg). After 24 h
the protein levels of γGCL-M, γGCL-C, Nrf2, PGC-1α and MnSOD were increased in parallel
with decreased levels of Keap1. These effects were correlated with increased level of
phosphorylated Akt and elevated acetylation of histone 4. In contrast, 72 h following LPS a
decrease in the components of the Nrf2 system in parallel with an increase of Keap1 was
observed. The down-regulation after 72 h correlated with phosphorylation of p38 MAPK, while
there were no changes in PGC-1α and MnSOD protein levels or the acetylation/methylation
pattern of histones.
Conclusion—Systemic LPS in neonatal rats induced time dependent changes in brain Nrf2 and
PGC-1α that correlated well with the protective effect observed after 24 h (preconditioning) and
the deleterious effects observed after 72 h (sensitizing) of systemic LPS reported earlier.
Collectively, the results point towards Nrf2 and PGC-1α as a possible mechanism behind these
effects.
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Introduction
Excitotoxicity, oxidative stress and inflammation are tightly interrelated factors in the
neurotoxic process in acute ischemia and chronic neurodegenerative diseases [1,2]. Down
regulation of anti-oxidant systems promotes oxidative stress and inflammation caused by
excitotoxicity [3]. The transcription factor nuclear factor-E2-related factor-2 (Nrf2), a
member of the “cap ‘n collar” group of transcription factors, is essential for protecting cells
against oxidative damage [4]. Deletion of Nrf2 makes animals over-sensitive to oxidative
stress and they develop white matter damage and retinopathy spontaneously [3,5,6].
Interestingly brains from Alzheimer patients demonstrate low levels of Nrf2 in hippocampal
astrocytes [7] indicating inadequate astroglial antioxidant support in this disease. Studies
done in Nrf2 knockout mice show larger infarct volume after cerebral ischemia; and tBHQ
(tertbutylhydroquinone), an Nrf2 activator, limited the damage in the penumbra region but
not in the core of infarction area in wild type animals only [8]. Similarly, the Nrf2 inducers
sulphoraphane, curcumin and (-)epicatechin have shown protective effects after transient
middle cerebral artery (MCA) occlusion [9-11]. The endogenous induction of the Nrf2
system in the peri-infarct region [8] is, at least partly, likely due to down-regulation of the
cytoplasmatic protein Keap1 that sequesters Nrf2 [12]. Regulation of the inducible anti-
oxidant system in neonatal CNS has not been studied in great detail, however, it has been
shown that the Nrf2 activator sulphoraphane can protect against neonatal hypoxia-ischemia
in rats [13]. Our earlier studies showed that the level of glutathione (GSH) was decreased in
brain after hypoxia-ischemia [14]. In a later study we demonstrated that the reduction in
GSH levels was more pronounced when the hypoxia-ischemia was preceded by
inflammation induced by lipopolysaccharide (LPS) injection in postnatal day (PND) 8 rats
72 h prior to the insult [15]. Both the brain damage and the decrease in GSH were
normalized by multiple injections of the anti-oxidant and GSH precursor N-acetylcysteine,
indicating that GSH synthesis was reduced by the inflammation [15]. In contrast, LPS
injection 24 h prior to hypoxia-ischemia protected against brain damage [16]. In a recent
study in vitro we mimicked these effects of neuroinflammation in vivo by activating
microglia with endotoxin and studied the effects of microglia conditioned medium on the
Nrf2 system in astrocytes after 24 and 72 h of treatment. These studies showed that
inflammation may have dual, time related, effects on the Nrf2 system that were dependent
on protein kinase activation, i.e. activation of Akt, JNK and ERK stimulated the Nrf2 system
whereas sustained activation of GSK3β and p38 down-regulated the system [17]. Another
factor that has complementary effects on the anti-oxidants system is the peroxisome
proliferator-activated receptor gamma (PPARγ) coactivator-1 alpha (PGC-1α), which
functions as a cofactor for many transcription factors [18]. Activation of PGC-1α results in
elevated levels of Mn-superoxide dismutase (MnSOD) present in the mitochondria. Earlier it
has been shown that LPS treatment increases MnSOD, both in vitro and in vivo [19,20].
Here we have employed the in vivo model and investigated how inflammation by systemic
LPS (0.3 mg/kg of LPS (i.p.)) affects the Nrf2 and PGC-1α systems in the brain after 24 and
72 h.
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Materials and Methods
Animal treatment and Tissue Preparation
Sprague-Dawley rats from our in-house colony were housed in a 12 h light-dark cycle and
bred at Experimental Biomedicine (Gothenburg University, Gothenburg, Sweden) and were
provided with a standard laboratory chow diet (B&K, Solna, Sweden) and drinking water ad
libitum. All animal experiments were approved by the Ethical Committee of Gothenburg
(Ethical number 264-2009) and followed the guidelines for the care and use of experimental
animals and the European Communities Council Directive of 24 November 1986 (86/609/
EEC).
Rats were injected intraperitoneally (i.p.) with saline or LPS (0.3 mg/kg) at PND 7 and brain
tissue was collected at 24 h (saline group = 9, LPS group = 11) and 72 h (saline group = 9,
LPS group = 11) after LPS exposure for western-blot assessment. Animals were deeply
anesthetized and perfused intracardially with ice-cold saline. Brains were rapidly removed
and frozen in liquid nitrogen and stored at −80°C until further use.
After thawing, ice-cold isolation buffer (50 mM Tris, pH 7.3; 2 mM EDTA, 1% protease
inhibitor cocktail) was added and homogenization was performed gently with a manual
homogenizer (VWR International). The cytosolic and nuclear fractions were separated
according to a method described previously (Wang et al., 2003). Briefly, the homogenates
were centrifuged at 800 × g at 4°C for 10 min. The pellets were washed in homogenizing
buffer and recentrifuged, producing a crude nuclear pellet (P1). The supernatant was further
centrifuged at 9200 × g for 15 min at 4°C, producing a crude mitochondrial fraction in the
pellet (P2) and a cytosolic fraction in the supernatant (S). All fractions were stored at −
80°C. P1 and S fractions were used for immunoblotting.
Western Blot Analysis
Homogenate fractions were mixed with 5X Laemmle sample buffer and boiled for 5 min.
Then equal amount of protein (30 μg) were resolved on 10% SDS-PAGE in a MOPS or
MES buffer (Invitrogen; Carlsbad, USA) and electroblotted at 40 V for 70 min at 4 °C to
nitrocellulose (Bio-Rad; Hercules, USA). The membranes were blocked for 1 h at room
temperature (RT) in 5 % (w/v) dry skimmed milk (Semper Mjölk; Sundyberg, Sweden) in
TBS with 0.1 % Tween 20 (TBST). Then, the membranes were incubated overnight at 4 °C
with the corresponding primary antibodies in 5% bovine serum albumin (BSA)-TBST,
extensively washed with TBST solution and incubated with the correspondent secondary
antibodies for 1 h at RT. Finally, the blots were rinsed and the peroxidase reaction was
developed by enhanced chemiluminescence SuperSignal® West Dura Extended Duration
Substrate (Thermo Scientific; Rockford, USA). Blots were stripped in RestoreTM Plus
Western Blot Stripping Buffer (Thermo Scientific; Rockford, USA) and were reprobed
sequentially.
Images were captured with a Fujifilm Image Reader LAS-1000 Pro v2.6 (Stockholm,
Sweden) and the different band intensities (density arbitrary units) corresponding to
immunoblot detection of protein samples were quantified using the Fujifilm Multi Gauge
v3.0 software (Stockholm, Sweden).
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Antibodies
Anti-Histone H2B, anti-acetyl-Histone H3, anti-acetyl-Histone H4 and anti-trimethyl-Lys9-
Histone H3 were from Millipore (Solna, Sweden). Anti-phospho-p38 and anti-phospho-Akt
were from New England Biolabs (Beverly, USA). Anti-Nrf2 was from R&D Diagnostics
(Minneapolis, USA). Anti-Keap1, anti-PGC-1α, anti-actin, anti-α-tubulin, anti-γGCL-C and
anti-γGCL-M antibodies were from Santa Cruz Biotechnology (Heidelberg, Germany).
Anti-MnSOD was from Lab Frontier (Seoul, South Korea). Peroxidase-conjugated anti-
rabbit and anti-mouse secondary antibodies were from Vector Laboratories (Burlingame,
USA).
Statistical Analysis
Results are presented as means ± standard error mean (SEM). Student's t test was used to
determine statistical significance (95%; p<0.05). If the Levene's test for homogeneity of
variances was significant then the nonparametric Mann-Whitman U test was used.
Results
Effect of 24 h systemic LPS exposure on the cerebral Nrf2 system
In our earlier studies we showed that conditioned medium from LPS activated microglia can
have positive effects after 24 h but negative effects after 72 h on the Nrf2-system in
astrocyte-rich cultures [21]. Similarly dual effects of LPS with protection after 24 h and
sensitisation after 72 h to a hypoxic-ischemic insult was demonstrated in neonatal rats [15].
Therefore we evaluated the effects of systemic LPS after 24 and 72 h on the Nrf2 system in
vivo in this study.
The effects of 24 h exposure of 7-day old rats to 0.3 mg/kg LPS (i.p.) on the components of
the brain inducible Nrf2 and PGC-1α systems are illustrated in Fig 1. We first analysed the
effects of LPS on cerebral Nrf2, Keap1, γGCL-C and γGCL-M protein expression (fig 1A).
As shown in Fig. 1B, the densitometric analysis of western blot showed that 24 h systemic
LPS induced an increased expression of Nrf2, γGCL-C and γGCL-M but reduced the level
of Keap1. Similarly, 24h after LPS exposure, there was an increase in the protein levels of
PGC1α and MnSOD (fig 1C) as shown in the densitometric analysis (fig 1D).
Moreover, we analysed the cytoplasmic and nuclear fractions of the brain homogenates and
found that there was an increase in Nrf2 protein levels in both fractions (fig 2).
To investigate the possible mechanisms relevant to the Nrf2 related changes observed above,
we further analysed changes of the MAPK signal pathway and cerebral acetylation and
methylation patterns of histones. The analysis of the MAPK signalling pathways activated in
the brain by the systemic administration of LPS (24 h) showed increased phosphorylation
levels of Akt (fig 3A). The levels of phosphorylated p38 MAPK and JNK were below
detection limits. The systemic treatment with LPS for 24 h also induced changes in the
cerebral acetylation and methylation of histones. Thus, an increase in the acetylation of
histone H4 and in the methylation of histone H3-K9 was detected with no changes in the
acetylation pattern of H3, as revealed in figure 3C and 3D.
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Effect of 72 h systemic LPS on the cerebral Nrf2 system
The effects of 72 h exposure to 0.3 mg/kg LPS (i.p.) on the components of the brain
inducible Nrf2 and PGC1α systems in 7-day old rats are shown in Fig 4. We first analysed
the effects of LPS on cerebral Nrf2, Keap1, γGCL-C and γGCL-M protein expression (fig.
4A). The densitometric analysis of western blot bands showed that 72 h after systemic LPS
injection expression of Nrf2, γGCL-C and γGCL-M was lower, but higher levels of Keap1
were observed when compared to saline treatment (fig. 4B). Next, the protein levels of
PGC1α and MnSOD were analysed (fig. 4C), however no changes were observed, as shown
in the densitometric analysis (fig. 4D).
When the cytoplasmic and nuclear fractions were analysed, we found that in both fractions
the protein levels of Nrf2 were reduced compared to saline control (fig. 5).
The analysis of the signalling pathways activated in the brain by the systemic administration
of LPS (72 h) showed unchanged phosphorylation levels of Akt with a concomitant increase
in the phosphorylation levels of p38 MAPK (fig. 6A and 6B). Both JNK and ERK1/2 were
below detection limits (data not shown). Interestingly, 72h following the systemic treatment
with LPS there were no changes in the cerebral acetylation and methylation pattern of
histones, albeit a tendency to a lower acetylation levels of histone H3 which did not reach
statistical significance (fig. 6C and 6D).
Discussion
LPS elevated the protein levels of Nrf2 and its down-stream products, γGCLM and γGCLC
24 h after systemic administration. This is in agreement with our earlier finding that
systemic LPS in neonatal rats increased brain levels of Nrf2 mRNA after 24 h [22]. In
addition, the complementary transcriptional co-factor PGC-1α and MnSOD, which
transcription is elevated by PGC-1α, were raised at this time point. These effects point
towards an induced anti-oxidant defence by LPS at 24 h after treatment. Such elevation in
the anti-oxidant systems may well underlie our previously observed preconditioning effect
and protection by LPS in neonatal rats at 24 h after administration [16]. This also agrees
well with the induction of the Nrf2 system 24 h after LPS exposure that we observed with
microglia conditioned medium in primary astrocytes [21].
The mechanism behind the increase in the Nrf2 system 24 h after LPS administration could
be related to activation of certain kinases. We observed previously that inhibition of
ERK1/2, Akt and JNK reduced Nrf2 mediated transcription in astrocytes [17,21]. This is in
accord with a recent report showing that LPS stimulated expression of HO-1, a down-stream
product of Nrf2 transcription, involved Akt and ERK1/2 activation [23]. In the present study
the levels of phosphorylated/activated Akt were increased 24 h after LPS exposure (JNK
was below detection limit and ERK1/2 too variable). It is thus possible that the observed
protection against hypoxic-ischemic injury 24 h after LPS treatment is partly mediated via
activation of Akt, in accordance with earlier studies on hypoxic preconditioning in vivo [24].
In parallel with the activation of the Nrf2 system 24 h after LPS exposure we observed a
profound down-regulation of the sequester protein Keap1. Similar down-regulation of
Keap1 and up-regulation of Nrf2 has also been observed in the brain after MCA occlusion in
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adult mice [12]. The reason for the opposite effects on Nrf2 and Keap1 levels might be that
activation of Nrf2 shifts the ubiqutination (and degradation) from Nrf2 to Keap1 [25].
One additional mechanism that may be involved in the observed positive effects on the Nrf2
system is the acetylation of proteins, i.e. histones, transcription factors or both. We recently
showed that down-regulation of the Nrf2 system by medium from LPS (10 ng/mL) activated
microglia was parallel to decreased acetylation of H3 and elevated trimethylation of H3-K9.
These effects of microglia conditioned medium on both the Nrf2 system and the histone
acetylation levels were reversed by HDAC inhibitors [17]. Here activation of the Nrf2
system was accompanied by elevated acetylation of H4 and increased tri-methylation of H3.
On the basis of a study showing that TNFα and H2O2 elevate H4 histone acetylation in vitro
[26] we hypothesize that the elevated acetylation level of H4 in vivo may be related to TNFα
or oxidative stress induced by systemic LPS treatment.
The levels of H3-K9 trimethylation was elevated 24 h after systemic LPS but restored to
control levels after 72 h. Trimethylation of H3-K9 is generally associated with repression of
transcription and dimethylation of H3-K9 with binding of DNA-methylases that can cause
more persistent epigenetic modification of CpG islands in various promoters [27]. These
effects of H3-K9 may thus underlie the down-regulation of genes in the rat brain after
systemic administration of LPS [16]. However, it should be noted that H3-K9 trimethylation
in transcribed regions has been correlated with active gene transcription rather than
transcriptional repression [28]. Obviously, to confirm the potential significance of the H3-
K9 trimethylation on Nrf2/PGC-1α mediated transcription further more detailed studies are
needed.
The increased acetylation levels of H4 imply elevated activity of histone acetyl transferases
(HATs), which implicate that also Nrf2 is acetylated. Elevated acetylation of Nrf2 by HATs
such as CBP increases transcription mediated by Nrf2 which could be one mechanism
behind the upregulation of the Nrf2 system observed in our study [29]. The apparent
elevated HAT activity could be related to the increase in Akt activation as nuclear Akt
interacts with and phosphorylates p300 in response to TNFα [30].
Upregulation of MnSOD after LPS treatment in adult rats has been observed earlier in vivo
and in vitro studies [20]. In that study LPS administration reduced infarct area when given
72 h prior to MCA occlusion [20]. The levels of MnSOD were measured 12 and 72 h
following LPS but were only increased after 72 h. In our case we observed a significant
increase in MnSOD after 24 h but no increase at 72 h after LPS. The apparent discrepancy
between the results most certainly relates to the differences in models, i.e. we used 7-day old
rats and 0.3 mg LPS/kg whereas Bordet and co-workers employed adult rats and 0.5 mg
LPS/kg. TNFα was suggested to mediate the protective effects of LPS treatment and the
increase in MnSOD [20].
After 72 h the effect of systemic LPS administration on the Nrf2 system was more or less
reversed in the present study, i.e. Nrf2, γGCL-M and γGCL-C levels were down-regulated
whereas Keap1 levels were higher compared to saline treated controls. This is in most
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respects similar to our results in vitro on the effects of microglia conditioned medium on the
Nrf2 system in astrocyte cultures [17,21].
We have earlier evaluated the role of kinases in the up- and down-regulation of the Nrf2
system [17,21]. These studies in vitro showed that microglia conditioned medium exert
negative effects on the Nrf2 system via p38 MAPK and GSK3β activation whereas positive
effects were observed for activation of JNK, ERK, Akt/PI3 kinase. Here we analysed
activation of p38 and Akt (phosphorylated GSK3β and JNK were below detection limit and
ERK1/2 showed too high variation). The level of phosphorylated p38 MAPK was
upregulated at 72 h after LPS administration, in accordance with our previous in vitro
studies showing that when the Nrf2 system was down-regulated, p38 MAPK was
phosphorylated. The elevated level of p38 MAPK can probably explain the decreased level
of Nrf2 in the nucleus. Genetic deletion and pharmacological inhibition of p38 MAPK have
earlier been shown to increase export of p38 MAPK from the nucleus and to decrease Nrf2
mediated transcription of phase II genes [31,32].
As noted above we have shown that medium from 72 h LPS (10 ng/mL) activated microglia
down-regulated the Nrf2 system in astrocytes, which occurred in parallel to decreased
acetylation of H3, H4, elevated activity of HDACs and increased tri-methylation of H3-K9.
The effects on both the Nrf2 system and the histone acetylation levels were reversed by
HDAC inhibitors, which also protected against oxidative stress induced cell damage.
Interestingly, the deacetylation was obliterated by inhibitors of p38 MAPK and GSK3β [17].
Here we did not observe any significant changes in H3 acetylation after 72 h although a
trend towards decreased acetylation was observed. The data show clearly that between 24
and 72 h the acetylation level of H4 is decreased, meaning that either the H4 acetylation by
HATs is decreased or that the high acetylation level at 24 h is decreased by elevated HDAC
activity. This fits well with our in vitro results where we showed that after 72 h but not after
24 h microglia conditioned medium caused elevated HDAC activity in astrocytes [17].
In summary, systemic LPS in neonatal rats induced time dependent changes in Nrf2 and
PGC-1α that correlated well with the protective effect after 24 h and the deleterious effects
after 72 h of systemic LPS reported earlier [15,16]. Thus, up-regulations of Nrf2, the
modulatory and catalytic subunits of γGCL as well as PGC-1α and MnSOD were observed
at 24 h after LPS treatment whereas Nrf2 and γGCL subunits were down-regulated and,
PGC-1α and MnSOD were normalised at 72 h following LPS treatment. The positive effects
on the inducible anti-oxidant defense after 24 h correlated with activated Akt and increased
acetylation of H3 whereas the negative effect after 72 h was in parallel with elevated p38
MAPK activation and normalised Akt and H3 acetylation.
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Abbreviations
γGCL gamma-glutamylcysteine ligase
γGCL-C gamma-glutamylcysteine ligase catalytic subunit
γGCL-M gamma-glutamylcysteine ligase modulatory subunit
GSH glutathione
GSK3β glycogen synthase kinase-3 beta
GSH glutathione
Keap1 Kelch-like ECH-associated protein 1
ERK1/2 extracellular regulated kinase
JNK c-Jun N-terminal kinase
H3-K9 lysine 9 in histone-3
LPS lipopolysaccaride
MAPKs mitogen-activated protein kinases
MCM microglia-conditioned medium
MEK mitogen-activated protein kinase kinase
MnSOD manganese-superoxide dismutase
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells
Nrf2 nuclear factor-erythroid 2-related factor 2
PGC-1α peroxisome proliferator-activated receptor gamma coactivator-1 alpha
tBHQ tertbutylhydroquinone
TNFα tumor necrosis factor-alpha
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Fig. 1.
Systemic LPS (0.3 mg/kg i.p.) induced the antioxidant defence systems after 24 h. Seven-
day old rat pups were exposed to either saline (n = 9) or LPS (0.3 mg/kg) (n = 11) for 24 h
after which their brains were removed for the protein expression analysis of Nrf2, Keap1,
γGCL-C and γGCL-M subunits was analysed (A). In (B), the densitometric analysis of
western blot is shown. Statistics: *p<0.05 vs saline; **p<0.01 vs saline; ***p<0.005 vs
saline; #p<0.05 vs saline (Mann-Whitman U test). A similar analysis was performed for the
protein expression of PGC-1α and MnSOD (C). In (D), the densitometric analysis shows:
****p<0.001 vs saline, **p<0.01 vs saline. Results are expressed as mean ± SEM.
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Fig. 2.
Nuclear and cytosolic extracts from brain homogenates of rats injected with LPS (0.3 mg/kg
i.p.) showed increased Nrf2 protein levels after 24 h. (A) The Nrf2 protein level in
cytoplasmic extract of brains of 7-day old rats 24 h after injection (i.p.) of either saline or
LPS (0.3 g/kg). The densitometric analysis of the western blots is shown in (B). Statistics:
**p<0.01 vs saline. (C) A similar analysis was performed for the protein expression of Nrf2
in the nuclear fraction. In (D), the densitometric analysis shows: *p<0.05 vs saline. Results
are expressed as mean ± SEM.
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Fig. 3.
(A) Systemic LPS (0.3 mg/kg i.p.) increased the level of phosphorylated Akt after 24 h. The
densitometric analysis of western blot is shown in (B). Statistics: **p<0.01 vs saline. (C)
Exposure for 24 h to LPS (0.3 mg/kg) i.p. modified the acetylation/methylation pattern of
histones H4 and H3. In (D), the densitometric analysis shows: *p<0.05 vs saline. Results are
expressed as mean ± SEM.
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Fig. 4.
Systemic LPS (0.3 mg/kg i.p.) caused decreased antioxidant defence levels after 72 h. (A)
Seven-day old rat pups were injected with saline (n = 11) or LPS (0.3 mg/kg) (n = 9) and
after 72 h their brains were removed for protein level analysis of Nrf2, Keap1, γGCL-C and
γGCL-M subunits. The densitometric analysis of western blot is shown in (B). Statistics:
*p<0.05 vs saline; ***p<0.005 vs saline. (C) A similar analysis was performed for the
protein expression of PGC-1α and MnSOD. No changes were observed in these protein
levels. The densitometric analysis is shown in (D). Results are expressed as mean ± SEM.
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Fig. 5.
Nuclear and cytosolic extracts from brain homogenates of rats injected with LPS (0.3 mg/kg
i.p.) showed decreased levels of Nrf2 protein levels after 72 h. (A) The levels of Nrf2
protein in the cytosolic fraction of brain extracts 72 h after injection of saline or LPS (0.3
mg/kg) in 7-day old rats. The densitometric analysis of western blot is shown in (B).
Statistics: ***p<0.005 vs saline. (C) A similar analysis was performed for the protein
expression of Nrf2 in the nuclear fraction. The densitometric analysis is shown in (D).
Statistics: *p<0.05 vs saline. Results are expressed as mean ± SEM.
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Fig. 6.
(A) Systemic LPS (0.3 mg/kg i.p.) activated p38 MAPK. In (B), the densitometric analysis
of western blot is shown. Statistics: *p<0.05 vs saline. (C) The acetylation pattern of Histone
H3, showed a tendency (although without statistical significance) to be down-regulated 72 h
following systemic LPS (0.3 mg/kg i.p.). In (D), the densitometric analysis is shown. Results
are expressed as mean ± SEM.
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